TrueBlue (NYSE: TBI) reported Q2 EPS of $0.51, $0.08 better than the analyst estimate of $0.43. Revenue for the quarter came in at $673 million versus the consensus estimate of $675.33 million.

“Although we reported a net loss in the quarter due to the impairment, adjusted EBITDA results exceeded our expectation,” TrueBlue CEO Steve Cooper said. “Revenue trends have been mixed this year, but we have managed our costs and are pleased with how our teams have continued to improve the spread between our bill rates and pay rates. We are taking the right steps to preserve our profit margin and continue producing long-term growth for shareholders.”

GUIDANCE:

TrueBlue sees Q3 2016 EPS of $0.73-$0.78, versus the consensus of $0.67. TrueBlue sees Q3 2016 revenue of $717-733 million, versus the consensus of $719.6 million.

For earnings history and earnings-related data on TrueBlue (TBI) click here.